Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
(1) Background/Objectives: Nail psoriasis (NP) is a chronic and difficult-to-treat disease, which causes significant social stigma and impairs the patients' quality of life. Moreover, nail psoriasis is a true therapeutic challenge for clinicians. The presence of nail psoriasis can be part of a...
Saved in:
Similar Items
-
Rapid response on facial psoriasis to bimekizumab: case series
by: Nicoletta Bernardini, et al.
Published: (2024) -
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience-IL PSO (Italian Landscape Psoriasis)
by: Diego Orsini, et al.
Published: (2024) -
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
by: Diego Orsini, et al.
Published: (2024) -
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
by: Annunziata Dattola, et al.
Published: (2024) -
Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature
by: Maria Concetta Fargnoli, et al.
Published: (2023)